ClinicalTrials.Veeva

Menu

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)

Merck Sharp & Dohme (MSD) logo

Merck Sharp & Dohme (MSD)

Status and phase

Completed
Phase 3

Conditions

Postoperative Pain

Treatments

Drug: MK0966, rofecoxib
Drug: Comparator: valdecoxib

Study type

Interventional

Funder types

Industry

Identifiers

NCT00092300
0966-181
2004_066

Details and patient eligibility

About

The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.

Full description

The duration of treatment is 1 day.

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Impaction of a molar tooth requiring removal

Exclusion criteria

  • Known allergies to the study drug

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems